Tag: Keisin Wang

Autologous bone marrow cell injection reduces one-year amputation rate for Rutherford...

Fifty-two-week outcomes of the MOBILE trial indicate a “significant reduction in major amputations” among Rutherford 4 and non-diabetic Rutherford 5 critical limb ischaemia patients...